Kevin Balthaser - 06 Sep 2023 Form 4 Insider Report for Aclaris Therapeutics, Inc. (ACRS)

Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Issuer symbol
ACRS
Transactions as of
06 Sep 2023
Net transactions value
+$74,971
Form type
4
Filing time
07 Sep 2023, 16:16:48 UTC
Previous filing
05 Sep 2023
Next filing
03 Jan 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACRS Common Stock Purchase $74,971 +9,490 +159% $7.90 15,461 06 Sep 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.